When adhered to, glucagon-like peptide 1 receptor agonist (GLP-1) prescriptions are a highly effective treatment for obesity. Clinical trials show GLP-1 treatment inducing weight loss of 10%-25% over a 1-2-year period. However, GLP-1s don’t cure obesity but treat it much like blood pressure medication attenuates hypertension. Remove the medication and the disease returns.
One promising way to promote drug adherence and lifestyle change is to provide health well-being coaching (HWC) alongside GLP-1 prescriptions.
Published on March 27, 2025
